
Embecta Investors File Class Action Following 57% Stock Collapse
A federal class action lawsuit now targets Embecta Corp. following a dramatic 57.8% share price collapse that wiped out significant investor value in a single day. The litigation claims the company issued misleading revenue guidance while internal records allegedly showed eroding demand for its core pen needle product line.


























